Competition in off-patent drug markets: Issues, regulation and evidence
Authors:
- 1 July 2008
- journal article
- Published by Oxford University Press (OUP) in Economic Policy
- Vol. 23 (55) , 499-544
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Pharmaceuticals in U.S. Health Care: Determinants of Quantity and PriceJournal of Economic Perspectives, 2002
- The Impact of Generic Drug Competition on Brand Name Market Shares – Evidence from Micro DataReview of Industrial Organization, 2001
- Does Regulation Drive Out Competition in Pharmaceutical Markets?The Journal of Law and Economics, 2000
- Importing budget systems from other countries: what can we learn from the German drug budget and the British GP fundholding?Health Policy, 2000
- Effects of financial incentives on medical practice: results from a systematic review of the literature and methodological issuesInternational Journal for Quality in Health Care, 2000
- The relative impact of actual and potential rivalry on firm profitability in the pharmaceutical industryStrategic Management Journal, 1999
- The Economics of Parallel TradePharmacoEconomics, 1998
- A physician survey on generic drugs and substitution of critical dose medicationsArchives of internal medicine (1960), 1997
- A prescribing incentive scheme for non-fundholding general practices: an observational studyBMJ, 1996
- Substitution Laws, Insurance Coverage, and Generic Drug UseMedical Care, 1994